000 01532 a2200457 4500
005 20250514211926.0
264 0 _c20050331
008 200503s 0 0 eng d
022 _a1566-5232
024 7 _a10.2174/1566523043346129
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aOehmig, Angelika
245 0 0 _aHerpes simplex virus type 1 amplicons and their hybrid virus partners, EBV, AAV, and retrovirus.
_h[electronic resource]
260 _bCurrent gene therapy
_cDec 2004
300 _a385-408 p.
_bdigital
500 _aPublication Type: Journal Article; Review
650 0 4 _aAnimals
650 0 4 _aDependovirus
_xgenetics
650 0 4 _aGenetic Engineering
650 0 4 _aGenetic Therapy
_xmethods
650 0 4 _aGenetic Vectors
650 0 4 _aGenome, Viral
650 0 4 _aHerpesvirus 1, Human
_xgenetics
650 0 4 _aHerpesvirus 4, Human
_xgenetics
650 0 4 _aHumans
650 0 4 _aHybridization, Genetic
650 0 4 _aMice
650 0 4 _aMoloney murine leukemia virus
_xgenetics
650 0 4 _aNucleic Acid Amplification Techniques
650 0 4 _aRecombination, Genetic
650 0 4 _aReplicon
650 0 4 _aRetroviridae
_xgenetics
650 0 4 _aVirus Integration
650 0 4 _aVirus Latency
650 0 4 _aVirus Replication
700 1 _aFraefel, Cornel
700 1 _aBreakefield, Xandra O
700 1 _aAckermann, Mathias
773 0 _tCurrent gene therapy
_gvol. 4
_gno. 4
_gp. 385-408
856 4 0 _uhttps://doi.org/10.2174/1566523043346129
_zAvailable from publisher's website
999 _c15263893
_d15263893